STOCK TITAN

Life360 director sells 4,000 shares at $41.97

Life360 director John Philip Coghlan reported a 4,000-share sale under a pre-established Rule 10b5-1 trading plan while retaining substantial direct and trust holdings.

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Life360, Inc. (LIF) director John Philip Coghlan, through the John Coghlan Living Trust, reported selling 4,000 shares of common stock on September 1, 2026 at a weighted average price of $41.97 per share, in transactions priced between $41.72 and $42.21 per share.

The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. Following the sale, the John Coghlan Living Trust held 16,431 shares indirectly, Coghlan held 5,676 shares directly (including 4,840 restricted stock units), and The John Philip Coghlan 2025 Grantor Retained Annuity Trust held 55,494 shares indirectly.

Positive

  • None.

Negative

  • None.
Insider COGHLAN JOHN PHILIP
Role Director
Sold 4,000 shs ($168K)
Type Security Shares Price Value
Sale Common stock F1, F2 4,000 $41.97 $168K
holding Common stock F3 -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common stock — 16,431 shares (Indirect, Held by the John Coghlan Living Trust); Common stock — 5,676 shares (Direct); Common Stock — 55,494 shares (Indirect, Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust)
Footnotes (3)
  1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  2. F2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $41.72 to $42.21 , inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  3. F3. Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Shares sold 4,000 shares Common stock sold on September 1, 2026 by the John Coghlan Living Trust
Weighted average sale price $41.97 per share Sale of 4,000 shares on September 1, 2026
Sale price range $41.72–$42.21 per share Multiple transactions comprising the 4,000-share sale
Trust holdings after sale (John Coghlan Living Trust) 16,431 shares Indirect ownership following the September 1, 2026 sale
Direct holdings after transaction 5,676 shares Includes 4,840 restricted stock units reported as directly held
RSUs included in direct holdings 4,840 restricted stock units Each RSU represents a contingent right to one share upon vesting
Holdings in 2025 Grantor Retained Annuity Trust 55,494 shares Indirect ownership via The John Philip Coghlan 2025 Grantor Retained Annuity Trust after the transaction
Rule 10b5-1 plan adoption date December 8, 2025 Date Coghlan adopted the trading plan used for this sale
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
restricted stock units financial
"Includes 4,840 restricted stock units, each of which represents a contingent"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Grantor Retained Annuity Trust financial
"Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.

FAQ

What insider transaction did Life360 (LIF) disclose for John Philip Coghlan?

Life360 reported that director John Philip Coghlan, via the John Coghlan Living Trust, sold 4,000 shares of common stock on September 1, 2026 at a weighted average price of $41.97 per share, with trades between $41.72 and $42.21.

Was the Life360 (LIF) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sale was effected under a Rule 10b5-1 trading plan adopted by John Philip Coghlan on December 8, 2025, which provides for automatic sales based on a predetermined formula.

What are John Philip Coghlan’s indirect holdings in Life360 (LIF) after this Form 4?

After the reported sale, the John Coghlan Living Trust held 16,431 shares of Life360 common stock, and The John Philip Coghlan 2025 Grantor Retained Annuity Trust held an additional 55,494 shares, both reported as indirect ownership.

How many Life360 (LIF) shares does John Philip Coghlan hold directly after the transaction?

The filing reports that John Philip Coghlan held 5,676 shares of Life360 common stock directly after the transaction, including 4,840 restricted stock units, each representing a contingent right to receive one share upon vesting.

What price range did the Life360 (LIF) insider sale cover?

The Form 4 notes that the 4,000 shares were sold at prices ranging from $41.72 to $42.21 per share, with a reported weighted average sale price of $41.97 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
COGHLAN JOHN PHILIP

(Last)(First)(Middle)
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310

(Street)
SAN MATEO CALIFORNIA 94403

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock09/01/2026S(1)4,000D$41.97(2)16,431IHeld by the John Coghlan Living Trust
Common stock5,676(3)D
Common Stock55,494IHeld by The John Philip Coghlan 2025 Grantor Retained Annuity Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $41.72 to $42.21 , inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
3. Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Remarks:
/s/ Jay Sood, as Attorney-in-Fact09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)